Terms: = Leukemia AND CCND3, P30281, 896, ENSG00000112576 AND Treatment
33 results:
1. BRD4 PROTAC degrader MZ1 exhibits anti-B-cell acute lymphoblastic leukemia effects via targeting ccnd3.
Ma L; Wang J; Yang Y; Lu J; Ling J; Chu X; Zhang Z; Tao Y; Li X; Tian Y; Li Z; Zhang Y; Sang X; Lu L; Wan X; Zhang K; Chen Y; Yu J; Zhuo R; Wu S; Pan J; Zhou X; Hu Y; Hu S
Hematology; 2023 Dec; 28(1):2247253. PubMed ID: 37594294
[TBL] [Abstract] [Full Text] [Related]
2. Circ_0001602 aggravates the progression of acute myeloid leukemia by regulating the miR-192-5p/ZBTB20 axis.
Wu W; Deng J; Chen C; Ma X; Yu L; Chen L
Hematology; 2023 Dec; 28(1):2240133. PubMed ID: 37585722
[TBL] [Abstract] [Full Text] [Related]
3. [Effects of Thiomersal on Apoptosis and Autophagy of leukemia Cell Lines].
Wang Y; Yao H; Li ZL; Yang K; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1655-1660. PubMed ID: 36476885
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis the influence factors of treatment free remission outcome with chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitors].
Zhao HF; Zhang Y; Dang LX; Liang JL; Chen SX; Guo Z; Li YL; Zu RR; Gui XD; Wei YP; Song Y
Zhonghua Yi Xue Za Zhi; 2022 May; 102(20):1523-1529. PubMed ID: 35692068
[No Abstract] [Full Text] [Related]
5. Phosphoproteomic profiling of T cell acute lymphoblastic leukemia reveals targetable kinases and combination treatment strategies.
Cordo' V; Meijer MT; Hagelaar R; de Goeij-de Haas RR; Poort VM; Henneman AA; Piersma SR; Pham TV; Oshima K; Ferrando AA; Zaman GJR; Jimenez CR; Meijerink JPP
Nat Commun; 2022 Feb; 13(1):1048. PubMed ID: 35217681
[TBL] [Abstract] [Full Text] [Related]
6. Advances in the treatment of Hairy Cell leukemia Variant.
Tran J; Gaulin C; Tallman MS
Curr Treat Options Oncol; 2022 Jan; 23(1):99-116. PubMed ID: 35178674
[TBL] [Abstract] [Full Text] [Related]
7. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.
Ueno H; Yoshida K; Shiozawa Y; Nannya Y; Iijima-Yamashita Y; Kiyokawa N; Shiraishi Y; Chiba K; Tanaka H; Isobe T; Seki M; Kimura S; Makishima H; Nakagawa MM; Kakiuchi N; Kataoka K; Yoshizato T; Nishijima D; Deguchi T; Ohki K; Sato A; Takahashi H; Hashii Y; Tokimasa S; Hara J; Kosaka Y; Kato K; Inukai T; Takita J; Imamura T; Miyano S; Manabe A; Horibe K; Ogawa S; Sanada M
Blood Adv; 2020 Oct; 4(20):5165-5173. PubMed ID: 33095873
[TBL] [Abstract] [Full Text] [Related]
8. [Efficacy of nilotinib in the first-line treatment of chronic myeloid leukemia and the analysis of factors affecting molecular responses].
Chen LY; Li Z; Zhang Y; Zhou J; Zhao HF; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):477-482. PubMed ID: 32654460
[No Abstract] [Full Text] [Related]
9. Recurrent
Matsuo H; Yoshida K; Fukumura K; Nakatani K; Noguchi Y; Takasaki S; Noura M; Shiozawa Y; Shiraishi Y; Chiba K; Tanaka H; Okada A; Nannya Y; Takeda J; Ueno H; Shiba N; Yamato G; Handa H; Ono Y; Hiramoto N; Ishikawa T; Usuki K; Ishiyama K; Miyawaki S; Itonaga H; Miyazaki Y; Kawamura M; Yamaguchi H; Kiyokawa N; Tomizawa D; Taga T; Tawa A; Hayashi Y; Mano H; Miyano S; Kamikubo Y; Ogawa S; Adachi S
Blood Adv; 2018 Nov; 2(21):2879-2889. PubMed ID: 30381403
[TBL] [Abstract] [Full Text] [Related]
10. Tight regulation of FOXO1 is essential for maintenance of B-cell precursor acute lymphoblastic leukemia.
Wang F; Demir S; Gehringer F; Osswald CD; Seyfried F; Enzenmüller S; Eckhoff SM; Maier T; Holzmann K; Debatin KM; Wirth T; Meyer LH; Ushmorov A
Blood; 2018 Jun; 131(26):2929-2942. PubMed ID: 29622548
[TBL] [Abstract] [Full Text] [Related]
11. Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Pandor A; Stevenson M; Stevens J; James MM; Hamilton J; Byrne J; Rudin C; Rawdin A; Wong R
Pharmacoeconomics; 2018 Aug; 36(8):903-915. PubMed ID: 29480454
[TBL] [Abstract] [Full Text] [Related]
12. The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples.
Wever CM; Geoffrion D; Grande BM; Yu S; Alcaide M; Lemaire M; Riazalhosseini Y; Hébert J; Gavino C; Vinh DC; Petrogiannis-Haliotis T; Dmitrienko S; Mann KK; Morin RD; Johnson NA
Leuk Lymphoma; 2018 Sep; 59(9):2159-2174. PubMed ID: 29295643
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic Drug Combinations with a CDK4/6 Inhibitor in T-cell Acute Lymphoblastic leukemia.
Pikman Y; Alexe G; Roti G; Conway AS; Furman A; Lee ES; Place AE; Kim S; Saran C; Modiste R; Weinstock DM; Harris M; Kung AL; Silverman LB; Stegmaier K
Clin Cancer Res; 2017 Feb; 23(4):1012-1024. PubMed ID: 28151717
[No Abstract] [Full Text] [Related]
14. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
[
